Medicus Pharma Ltd MDCX
0.15
(0.01)
(6.25%)
as of 25 Sep
- Market cap
- $10.0M
- P/E
- 0.0×
Follow MDCX
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | |
|---|---|---|---|---|
Current Ratio |
1.00 | 2.33 | 2.42 | 0.02 |
Net Debt/EBITDA |
0.25 | 0.37 | 0.36 | 0.27 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | — |
Operating CF/Net income |
0.48 | 0.92 | 0.78 | 0.62 |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 |
| (2,981.87%) | (525.45%) | 95.88% | 0.00% | |
| (602.13%) | (295.90%) | (488.54%) | 0.00% | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
99,562.95% | (363.12%) | (478.16%) | 13.87% |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | — |
Free Cash Flow per Share |
(1.32) | (1.07) | (1.20) | (0.28) |
Cash per Share |
0.50 | 0.43 | 0.49 | 0.07 |
Shareholders Equity per Share |
0.00 | 0.33 | 0.32 | (3.24) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.00 | 0.33 | 0.32 | (3.24) |
Free Cash Flow |
(22.78) | (10.25) | (4.16) | (1.06) |
Working Capital |
(0.05) | 3.07 | 1.11 | (12.20) |
Net Current Asset Value |
(0.13) | 2.87 | 1.11 | (12.20) |
| Other line items | ||||
Quick Ratio |
0.88 | 1.81 | 2.20 | 0.02 |
Cash ROIC |
(260.53%) | (140.39%) | (146.90%) | 8.86% |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(1.32) | (1.07) | (1.20) | (0.28) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Average Payables |
2.36 | 0.75 | 0.16 | — |
Average Assets |
7.85 | 3.77 | 1.09 | — |
Average Common Equity |
1.59 | 2.12 | (5.54) | — |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates